These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734 [TBL] [Abstract][Full Text] [Related]
6. [The therapeutic effect of TGF-beta monoclonal antibody to bleomycin-induced pulmonary fibrosis in rats]. Li J; He B; Weng B Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):347-9. PubMed ID: 10374444 [TBL] [Abstract][Full Text] [Related]
8. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice. Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573 [TBL] [Abstract][Full Text] [Related]
9. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity. Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567 [TBL] [Abstract][Full Text] [Related]
10. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663 [TBL] [Abstract][Full Text] [Related]
11. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice. Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017 [TBL] [Abstract][Full Text] [Related]
12. Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats. Gong LK; Li XH; Wang H; Zhang L; Chen FP; Cai Y; Qi XM; Liu LL; Liu YZ; Wu XF; Huang CG; Ren J J Ethnopharmacol; 2005 Jan; 96(3):537-44. PubMed ID: 15619575 [TBL] [Abstract][Full Text] [Related]
13. The role of high mobility group box1 in pulmonary fibrosis. Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281 [TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. Monneret G; Boumiza R; Gravel S; Cossette C; Bienvenu J; Rokach J; Powell WS J Pharmacol Exp Ther; 2005 Feb; 312(2):627-34. PubMed ID: 15388786 [TBL] [Abstract][Full Text] [Related]
15. [Effects of interleukin-17 on murine pulmonary fibroblast proliferation, transformation and collagen synthesis]. Dong Z; Kang Q; Lei W; Zhong H; Tai W; Wang D Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):75-9. PubMed ID: 22366009 [TBL] [Abstract][Full Text] [Related]
16. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis]. Gao JM; Lu B Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188 [TBL] [Abstract][Full Text] [Related]
17. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters. Wang Q; Hyde DM; Gotwals PJ; Giri SN Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Tager AM; Kradin RL; LaCamera P; Bercury SD; Campanella GS; Leary CP; Polosukhin V; Zhao LH; Sakamoto H; Blackwell TS; Luster AD Am J Respir Cell Mol Biol; 2004 Oct; 31(4):395-404. PubMed ID: 15205180 [TBL] [Abstract][Full Text] [Related]
19. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Aoki F; Kurabayashi M; Hasegawa Y; Kojima I Am J Respir Crit Care Med; 2005 Sep; 172(6):713-20. PubMed ID: 15976370 [TBL] [Abstract][Full Text] [Related]
20. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice. Gurujeyalakshmi G; Wang Y; Giri SN J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]